[go: up one dir, main page]

YU20097A - Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze - Google Patents

Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze

Info

Publication number
YU20097A
YU20097A YU20097A YU20097A YU20097A YU 20097 A YU20097 A YU 20097A YU 20097 A YU20097 A YU 20097A YU 20097 A YU20097 A YU 20097A YU 20097 A YU20097 A YU 20097A
Authority
YU
Yugoslavia
Prior art keywords
analogues
vitamin
preparation
fluorinated
hydrogen
Prior art date
Application number
YU20097A
Other languages
English (en)
Inventor
Sarwood Percy Manchand
Joseph John Nestor
Radoje Milan Uskoković
Henry Brian Vickery
Original Assignee
F. Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag. filed Critical F. Hoffmann-La Roche Ag.
Publication of YU20097A publication Critical patent/YU20097A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Movi fluorovani analozi vitamina D3 formule u kojoj oznacavaju X (H, H) ili =CH2, R1 i R2, nezavisno jedan od drugog, vodonik, (C1-C4)-alkil ili -fluoralkil, ili R1 i R2 zajedno sa C-20 formiraju (C3-C6)-cikloalkil ili -ciklofluoralkil, ili R1 i R2 zajedno formiraju =CH2, R3 i R4, nezavisno jedan od drugog, (C1-C4)-alkil ili fluoralkil, ili R3 i R4 zajedno sa C-25 formiraju (C3-C9)-cikloalkil ili -ciklofluoralkil, A prostu ili dvostruku vezu, i B dvostruku ili trostruku vezu, osim (i) kada X oznacava =CH2, R3 i R4 su svaki CF3, A je dvostruka veza i jedan od R1 ili R2 je vodonik, tada drugi od R1 ili R2 ne moze biti CH3, (ii) kada X oznacava =CH2, R3 i R4 su svaki (C1-C2)-alkil, A je dvostruka veza i R2 je vodonik, tada R1 ne moze biti CH3, (iii) kada X oznacava =CH2, R3 i R4 su svaki (C1-C4)-alkil, A je dvostruka veza i R1 je vodonik, tada R2 ne moze biti CH3, (iv) kada X oznacava =CH2, jedan od R3 ili R4 je CF3, A je dvostruka veza, R1 je CH3 i R2 je vodonik, tada drugi od R3 ili R4 ne moze biti CH3, i (v) kada je X vodonik, R3 i R4 su svaki CF3, A je dvostruka veza, B je trostruka veza i R2 je vodonik, tada R1 ne moze biti CH3, i jedinjenja gore date formule I u kojoj X je (H, H) ili =CH2, R1 i R2 su, nezavisno jedan od drugog, vodonik, (C1-C4)-alkil ili -fluoralkil, ili R1 i R2 zajedno sa C-20 formiraju (C3-C6)-cikloalkil ili -ciklofluoralkil, ili R1 i R2 zajedno formiraju =CH2, R3 i R4 su, nezavisno jedan od drugog, (C1-C4)-alkil ili -fluoralkil, ili R3 i R4 zajedno sa C-25 formiraju (C3-C9)-cikloalkil ili -ciklofluoralkil, A je prosta ili dvostruka veza, i B je dvostruka ili trostruka veza, osim kada su R3 i R4 svaki CF3 i A je dvostruka veza i B je trostruka veza i R2 je vodonik, tada R1 ne moze biti CH3, se koriste u lecenju osteoporoze.
YU20097A 1996-05-23 1997-05-20 Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze YU20097A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1821996P 1996-05-23 1996-05-23
US3990197P 1997-03-19 1997-03-19

Publications (1)

Publication Number Publication Date
YU20097A true YU20097A (sh) 1999-09-27

Family

ID=26690870

Family Applications (1)

Application Number Title Priority Date Filing Date
YU20097A YU20097A (sh) 1996-05-23 1997-05-20 Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze

Country Status (26)

Country Link
EP (1) EP0808832B1 (sh)
JP (1) JP2859248B2 (sh)
KR (1) KR100253961B1 (sh)
CN (1) CN100402497C (sh)
AR (1) AR007776A1 (sh)
AT (1) ATE238278T1 (sh)
AU (1) AU733970B2 (sh)
BR (1) BR9703385A (sh)
CA (1) CA2205315C (sh)
CO (1) CO4940503A1 (sh)
CZ (1) CZ157797A3 (sh)
DE (1) DE69721123T2 (sh)
DK (1) DK0808832T3 (sh)
ES (1) ES2195049T3 (sh)
HR (1) HRP970272A2 (sh)
HU (1) HUP9700928A3 (sh)
IL (1) IL120844A0 (sh)
MA (1) MA24250A1 (sh)
NO (1) NO972278L (sh)
NZ (1) NZ314840A (sh)
PE (1) PE66798A1 (sh)
PL (1) PL320130A1 (sh)
PT (1) PT808832E (sh)
SG (1) SG70010A1 (sh)
TR (1) TR199700416A2 (sh)
YU (1) YU20097A (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
WO2002013832A1 (fr) * 2000-08-17 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique destine au traitement de l'osteoporose
CA2459789A1 (en) * 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
PT103177A (pt) 2003-09-24 2005-03-31 Bioxell Spa 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CA2601914A1 (en) * 2005-03-23 2006-09-28 Bioxell S.P.A. 20-alkyl, gemini vitamin d3 compounds and methods of use thereof
CN104829510B (zh) 2010-10-25 2016-05-04 帝人制药株式会社 23-炔-维生素d3衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
AU7295696A (en) * 1995-10-27 1997-05-22 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis

Also Published As

Publication number Publication date
EP0808832B1 (en) 2003-04-23
HRP970272A2 (en) 1998-04-30
JP2859248B2 (ja) 1999-02-17
KR100253961B1 (ko) 2000-04-15
SG70010A1 (en) 2000-01-25
MX9703775A (es) 1998-06-30
CN100402497C (zh) 2008-07-16
PE66798A1 (es) 1998-10-22
CO4940503A1 (es) 2000-07-24
TR199700416A2 (xx) 1997-12-21
EP0808832A2 (en) 1997-11-26
CZ157797A3 (en) 1997-12-17
NZ314840A (en) 1998-11-25
NO972278L (no) 1997-11-24
AR007776A1 (es) 1999-11-24
ES2195049T3 (es) 2003-12-01
IL120844A0 (en) 1997-09-30
HUP9700928A3 (en) 1999-07-28
PL320130A1 (en) 1997-11-24
EP0808832A3 (en) 1999-02-03
HU9700928D0 (en) 1997-07-28
CN1172801A (zh) 1998-02-11
MA24250A1 (fr) 1998-04-01
ATE238278T1 (de) 2003-05-15
DE69721123D1 (de) 2003-05-28
DK0808832T3 (da) 2003-08-11
NO972278D0 (no) 1997-05-20
AU2357697A (en) 1997-11-27
PT808832E (pt) 2003-07-31
HUP9700928A2 (hu) 1998-01-28
JPH1045714A (ja) 1998-02-17
CA2205315A1 (en) 1997-11-23
DE69721123T2 (de) 2004-01-08
KR970074764A (ko) 1997-12-10
BR9703385A (pt) 1998-09-15
AU733970B2 (en) 2001-05-31
CA2205315C (en) 2006-10-24

Similar Documents

Publication Publication Date Title
KR890011837A (ko) 디데하이드로 비타민 d₃유도체
ES2139943T3 (es) Nuevos inhibidores de la sintasa de prostaglandina.
YU20197A (sh) Analozi vitamina d3, farmaceutske kompozicije koje ih sadrže kao aktivnu materiju i njihova upotreba u proizvodnji farmaceutskih kompozicija
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
ES479272A1 (es) Un procedimiento para la preparacion de esteres de acidos 17beta-tiocarboxilicos de 4-halo-3-oxoandrost-4-enos.
YU20097A (sh) Fluorovani analozi vitamina d3, intermedijeri za njihovo dobijanje, postupak za dobijanje takvih fluorovanih analoga vitamina d3, farmaceutska smeša koja sadrži analoge fluorovanog vitamina d3 i upotreba takvih analoga u proizvodnji farmaceutske smeše za lečenje osteoporoze
DE69015736D1 (de) 7-Keto- und 7-Hydroxy-androsta-3,5-dien-3-carbonsäure Derivate.
ES8701761A1 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ATE21246T1 (de) Substituierte imidazol-derivate mit pharmakologischer wirkung sowie ihre herstellung und verwendung.
ATE45347T1 (de) Vitamin d3-derivate.
ES484553A1 (es) Un metodo para preparar 4-fenil-1,3-benzodiazepinas
IL76538A0 (en) Alkylpiperazino substituted indane derivatives and methods of preparation and treatment and pharmaceutical compositions containing them
ES8506575A1 (es) Procedimiento para la preparacion de nuevos derivados de acidos fenilalcanoicos.
DE69806152D1 (de) Vitamin d3 analoga mit bis-c-20-seitenketten
DE69132050D1 (de) Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
AU586477B2 (en) Hexenoic acids
ES2055429T3 (es) Proceso para preparar derivados del acido 9-alfa-hidroxi-3-oxo-4,24(25)-estigmastadieno-26-oico, asi como composiciones farmaceuticas que contienen estos compuestos.
ES2038612T3 (es) Compuestos de hidroquinolina, composiciones que los contienen y procedimientos para prepararlas.
ES8308562A1 (es) Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas
EP0149583A3 (fr) 3-Alkoxy-2(N-pyrrolidino)-N-pyridyl-N-furyl (ou thienyl)-methyl-propylamines, leur préparation et les compositions pharmaceutiques les contenant
ES2093226T3 (es) Retinoides sustituidos con un ciclo ditiano y su empleo, procedimiento de preparacion de dichos compuestos, composiciones cosmetica y farmaceutica que los contienen y empleo terapeutico de esta ultima.
YU10397A (sh) Derivati 1,25-dihidroksi-16,22,23-trisdehidro -holekalciferola postupak za njihovu proizvodnju, njihovo korišćenje i farmaceutske smeše koje ih sadrže
US3989736A (en) Prostaglandin 5-indanyl esters
ECSP972132A (es) Analogos de vitamina d3 fluorinados (caso ran 4212/74)